Indoco Remedies Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2016
January 27, 2017 at 06:18 am
Share
Indoco Remedies Limited announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, the company reported total income from operations of INR 2,781.9 million compared to INR 2,604.3 million a year ago. Profit from operation before other income, finance costs, and exceptional items were INR 251.5 million compared to INR 275.3 million a year ago. Profit from ordinary activities before tax was INR 233.6 million compared to INR 221.1 million a year ago. Net profit for the period was INR 175.9 million or INR 1.91 per basic and diluted share compared to INR 189.8 million or INR 2.06 per basic and diluted share a year ago.
For the nine months, the company reported total income from operations of INR 8,163.5 million compared to INR 7,417.2 million a year ago. Profit from operation before other income, finance costs, and exceptional items were INR 754.2 million compared to INR 850.6 million a year ago. Profit from ordinary activities before tax was INR 709.5 million compared to INR 760.2 million a year ago. Net profit for the period was INR 595.1 million or INR 6.45 per basic and diluted share compared to INR 613.4 million or INR 6.65 per basic and diluted share a year ago.
Indoco Remedies Limited is an India-based manufacturer of pharmaceutical products. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company offers medicines in multiple therapeutic categories, such as diabetology, respiratory, stomatology, women's health, nutritional products, gastroenterology, cardiology, metabolic disorders and primary care medicine. Its products/brands include Cyclopam, Sensodent-K, Karvol Plus, Sensoform, Cital UTI, Kidodent, Rexidin M, Lignox A, Dentogel, Aloja, Homide, Renolen, Noxa, Dexoren - S, Aloja M, ATM, Febrex Plus, Sensodent-KF, SM Fibro, MCBM 69, Cal Aid, Snowdent, Dropizin, Zincoren, Coloferrin, Bfloren, RR Sensoform Dental, Mofloren-D, and Tuspel among others. The Company caters to both domestic and international markets. Its subsidiaries include Xtend Industrial Designers and Engineers Pvt Ltd, Indoco Remedies Czech sro, and Indoco Remedies UK Limited.